Atchison Jordan, Kamila Sukanta, McEwan Conor, Nesbitt Heather, Davis James, Fowley Colin, Callan Bridgeen, McHale Anthony P, Callan John F
Biomedical Sciences Research Institute, University of Ulster, Coleraine, Northern Ireland BT521SA, UK.
Engineering Research Institute, University of Ulster, Jordanstown, Northern Ireland BT37 0QB, UK.
Chem Commun (Camb). 2015 Dec 7;51(94):16832-5. doi: 10.1039/c5cc07022h.
A new sensitiser (4) for use in photodynamic therapy (PDT) has been developed to enable control of ROS production as a function of pH. This pH dependent PDT behaviour was tested in HeLa cells and in SCID mice bearing human xenograft pancreatic cancer (BxPC-3) tumours.
一种用于光动力疗法(PDT)的新型敏化剂(4)已被开发出来,以实现根据pH值控制活性氧(ROS)的产生。这种依赖于pH值的光动力疗法行为在HeLa细胞和携带人异种移植胰腺癌(BxPC-3)肿瘤的重症联合免疫缺陷(SCID)小鼠中进行了测试。